A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Multi-center Phase II Trial of Weekly Paclitaxel Plus Cisplatin Combination Chemotherapy in Patients with Advanced Gastric and Gastro-esophageal Cancer
Japanese Journal of Clinical Oncology
Objective: This study is performed to evaluate the response rate, time to progression and safety of the combination chemotherapy with weekly paclitaxel plus cisplatin in advanced gastric and gastro-esophageal cancer. Methods: The paclitaxel 100 mg/m 2 was administered through a 1 h intravenous infusion on Days 1 and 8. The cisplatin 30 mg/m 2 was also administered along with a program of forced diuresis that included at least 2000 ml of fluids after the paclitaxel infusion over 30 min on Days 1doi:10.1093/jjco/hyp008 pmid:19264768 fatcat:t7dqpmxaxjgbzfek742g7igfu4